Unknown

Dataset Information

0

Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome?


ABSTRACT:

Background and objectives

There is controversy surrounding whether or not high dose statin administration before percutaneous coronary intervention (PCI) decreases peri-procedural microvascular injury. We performed a prospective randomized study to investigate the mechanisms and effects of pre-treatment high dose atorvastatin on myocardial damage in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) undergoing PCI.

Subjects and methods

Seventy seven patients with NSTE-ACS were randomly assigned to either the high dose group (atorvastatin 80 mg loading 12 to 24 h before PCI with a further 40 mg loading 2 h before PCI, n=39) or low dose group (atorvastatin 10 mg administration 12 to 24 h before PCI, n=38). Index of microcirculatory resistance (IMR) was measured after stent implantation. Creatine kinase-myocardial band (CK-MB) and high sensitivity C-reactive protein (CRP) levels were measured before and after PCI.

Results

The baseline characteristics were not different between the two patient groups. Compared to the low dose group, the high dose group had lower post PCI IMR (14.1±5.0 vs. 19.2±9.3 U, p=0.003). Post PCI CK-MB was also lower in the high dose group (median: 1.40 ng/mL (interquartile range [IQR: 0.75 to 3.45] vs. 4.00 [IQR: 1.70 to 7.37], p=0.002) as was the post-PCI CRP level (0.09 mg/dL [IQR: 0.04 to 0.16] vs. 0.22 [IQR: 0.08 to 0.60], p=0.001).

Conclusion

Pre-treatment with high dose atorvastatin reduces peri-PCI microvascular dysfunction verified by post-PCI IMR and exerts an immediate anti-inflammatory effect in patients with NSTE-ACS.

SUBMITTER: Lee BK 

PROVIDER: S-EPMC4965425 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome?

Lee Bong-Ki BK   Koo Bon-Kwon BK   Nam Chang-Wook CW   Doh Joon-Hyung JH   Chung Woo-Young WY   Cho Byung-Ryul BR   Fearon William F WF  

Korean circulation journal 20160721 4


<h4>Background and objectives</h4>There is controversy surrounding whether or not high dose statin administration before percutaneous coronary intervention (PCI) decreases peri-procedural microvascular injury. We performed a prospective randomized study to investigate the mechanisms and effects of pre-treatment high dose atorvastatin on myocardial damage in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) undergoing PCI.<h4>Subjects and methods</h4>Seventy seven patients  ...[more]

Similar Datasets

| S-EPMC5642560 | biostudies-literature
| S-EPMC10498246 | biostudies-literature
| S-EPMC6585398 | biostudies-literature
| S-EPMC5556196 | biostudies-other
| S-EPMC4902146 | biostudies-literature
| S-EPMC5876881 | biostudies-literature
| S-EPMC2795157 | biostudies-other
| S-EPMC10654664 | biostudies-literature
| S-EPMC8015979 | biostudies-literature
| S-EPMC10784020 | biostudies-literature